Vlad Coric
Chief Executive Officer at Biohaven Ltd.
Sits on 3 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Biohaven Ltd., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Royalty Pharma plc June 4, 202688.8%
-
Royalty Pharma plc May 12, 202599.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Royalty Pharma plc | Grant or award | +4,545 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +33,706 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +33,706 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +148,794 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +148,794 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +78,075 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +78,075 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +117,112 | — | — |
| Feb 5, 2026 | Veradermics Incorporated | Open-market purchase | +58,823 | $17.00 | $999,991 |
| Feb 5, 2026 | Veradermics Incorporated | Open-market purchase | +58,823 | $17.00 | $999,991 |
| Jan 5, 2026 | Biohaven Ltd. | Option exercise | +14,250 | — | — |
| Jan 5, 2026 | Biohaven Ltd. | Shares withheld for tax | −7,430 | $9.93 | $73,780 |
| Nov 13, 2025 | Biohaven Ltd. | Open-market purchase | +333,333 | $7.50 | $2,499,998 |
| Nov 13, 2025 | Biohaven Ltd. | Open-market purchase | +333,333 | $7.50 | $2,499,998 |
| May 13, 2025 | Royalty Pharma plc | Grant or award | +7,614 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.